Corient Private Wealth LP Decreases Stake in Cigna Group $CI

Corient Private Wealth LP lessened its position in shares of Cigna Group (NYSE:CI - Free Report) by 17.3% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 126,767 shares of the health services provider's stock after selling 26,608 shares during the period. Corient Private Wealth LP's holdings in Cigna Group were worth $34,947,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of CI. Wilkerson Advisory Group LLC purchased a new position in shares of Cigna Group in the 4th quarter valued at about $25,000. Osbon Capital Management LLC purchased a new position in Cigna Group in the second quarter valued at approximately $26,000. Johnson Financial Group Inc. acquired a new stake in Cigna Group during the second quarter worth approximately $29,000. Kemnay Advisory Services Inc. acquired a new stake in Cigna Group during the fourth quarter worth approximately $29,000. Finally, Prosperity Bancshares Inc purchased a new stake in shares of Cigna Group during the 4th quarter worth approximately $29,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently commented on the stock. Evercore assumed coverage on shares of Cigna Group in a research report on Wednesday, September 9th. They issued an "in-line" rating and a $290.00 target price on the stock. Raymond James Financial cut shares of Cigna Group from a "strong-buy" rating to an "outperform" rating and reduced their price target for the company from $350.00 to $320.00 in a research report on Monday, August 3rd. Jefferies Financial Group downgraded shares of Cigna Group from a "buy" rating to a "hold" rating and decreased their price objective for the company from $336.00 to $307.00 in a research note on Tuesday, August 4th. Wells Fargo & Company raised their price objective on Cigna Group from $305.00 to $307.00 and gave the stock an "equal weight" rating in a report on Friday, July 31st. Finally, Mizuho lifted their target price on Cigna Group from $330.00 to $340.00 and gave the stock an "outperform" rating in a research report on Monday, June 8th. Fifteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $337.10.

Cigna Group Stock Down 0.1%

CI stock opened at $280.51 on Monday. The company has a market cap of $74.12 billion, a price-to-earnings ratio of 11.61, a price-to-earnings-growth ratio of 0.96 and a beta of 0.31. The company has a fifty day moving average price of $283.31 and a 200 day moving average price of $280.77. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same period last year, the firm posted $7.20 EPS. Cigna Group's revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts expect that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group's dividend payout ratio is currently 25.82%.

Insider Buying and Selling

In other Cigna Group news, insider Everett Neville sold 617 shares of the stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the sale, the insider directly owned 5,053 shares of the company's stock, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of Cigna Group stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the transaction, the insider owned 25,880 shares in the company, valued at $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 22,730 shares of company stock valued at $6,293,359 over the last ninety days. 0.60% of the stock is owned by insiders.

Cigna Group Profile

The Cigna Group NYSE: CI is a global health services company that helps individuals, employers, health plans and government organizations access health care and related services. The company operates primarily through two businesses: Cigna Healthcare, which provides medical, behavioral health, dental and other health benefit products and services, and Evernorth Health Services, which offers pharmacy, care delivery and health benefits solutions.

Evernorth includes Express Scripts, a pharmacy benefit services provider that manages prescription drug benefits and operates home delivery and specialty pharmacy services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.